255 related articles for article (PubMed ID: 25757571)
1. Interferon-α inducible protein 6 impairs EGFR activation by CD81 and inhibits hepatitis C virus infection.
Meyer K; Kwon YC; Liu S; Hagedorn CH; Ray RB; Ray R
Sci Rep; 2015 Mar; 5():9012. PubMed ID: 25757571
[TBL] [Abstract][Full Text] [Related]
2. Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells.
Mee CJ; Harris HJ; Farquhar MJ; Wilson G; Reynolds G; Davis C; van IJzendoorn SC; Balfe P; McKeating JA
J Virol; 2009 Jun; 83(12):6211-21. PubMed ID: 19357163
[TBL] [Abstract][Full Text] [Related]
3. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P
PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454
[TBL] [Abstract][Full Text] [Related]
4. Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties.
Tawar RG; Colpitts CC; Timm J; Fehm T; Roggendorf M; Meisel H; Meyer N; Habersetzer F; Cosset FL; Berg T; Zeisel MB; Baumert TF
Hepatology; 2015 Sep; 62(3):726-36. PubMed ID: 26010076
[TBL] [Abstract][Full Text] [Related]
5. HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex.
Zona L; Lupberger J; Sidahmed-Adrar N; Thumann C; Harris HJ; Barnes A; Florentin J; Tawar RG; Xiao F; Turek M; Durand SC; Duong FH; Heim MH; Cosset FL; Hirsch I; Samuel D; Brino L; Zeisel MB; Le Naour F; McKeating JA; Baumert TF
Cell Host Microbe; 2013 Mar; 13(3):302-13. PubMed ID: 23498955
[TBL] [Abstract][Full Text] [Related]
6. Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes.
Ramanathan A; Gusarova V; Stahl N; Gurnett-Bander A; Kyratsous CA
PLoS One; 2016; 11(4):e0154498. PubMed ID: 27115873
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.
Krieger SE; Zeisel MB; Davis C; Thumann C; Harris HJ; Schnober EK; Mee C; Soulier E; Royer C; Lambotin M; Grunert F; Dao Thi VL; Dreux M; Cosset FL; McKeating JA; Schuster C; Baumert TF
Hepatology; 2010 Apr; 51(4):1144-57. PubMed ID: 20069648
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry.
Diao J; Pantua H; Ngu H; Komuves L; Diehl L; Schaefer G; Kapadia SB
J Virol; 2012 Oct; 86(20):10935-49. PubMed ID: 22855500
[TBL] [Abstract][Full Text] [Related]
9. CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry.
Harris HJ; Farquhar MJ; Mee CJ; Davis C; Reynolds GM; Jennings A; Hu K; Yuan F; Deng H; Hubscher SG; Han JH; Balfe P; McKeating JA
J Virol; 2008 May; 82(10):5007-20. PubMed ID: 18337570
[TBL] [Abstract][Full Text] [Related]
10. Single Particle Imaging of Polarized Hepatoma Organoids upon Hepatitis C Virus Infection Reveals an Ordered and Sequential Entry Process.
Baktash Y; Madhav A; Coller KE; Randall G
Cell Host Microbe; 2018 Mar; 23(3):382-394.e5. PubMed ID: 29544098
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection in mouse hepatoma cells co-expressing human CD81 and Sip-L.
Yeh CT; Lai HY; Yeh YJ; Cheng JC
Biochem Biophys Res Commun; 2008 Jul; 372(1):157-61. PubMed ID: 18474223
[TBL] [Abstract][Full Text] [Related]
12. A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha-Inducible Protein 6.
Liu X; Duan X; Holmes JA; Li W; Lee SH; Tu Z; Zhu C; Salloum S; Lidofsky A; Schaefer EA; Cai D; Li S; Wang H; Huang Y; Zhao Y; Yu ML; Xu Z; Chen L; Hong J; Lin W; Chung RT
Hepatology; 2019 Mar; 69(3):1004-1019. PubMed ID: 30199576
[TBL] [Abstract][Full Text] [Related]
13. Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry.
Riva L; Song OR; Prentoe J; Helle F; L'homme L; Gattolliat CH; Vandeputte A; Fénéant L; Belouzard S; Baumert TF; Asselah T; Bukh J; Brodin P; Cocquerel L; Rouillé Y; Dubuisson J
J Virol; 2018 May; 92(10):. PubMed ID: 29491159
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of hepatitis C virus infection by interferon-gamma through downregulating claudin-1.
Wei X; Jia ZS; Lian JQ; Zhang Y; Li J; Ma L; Ye L; Wang JP; Pan L; Wang PZ; Bai XF
J Interferon Cytokine Res; 2009 Mar; 29(3):171-8. PubMed ID: 19196072
[TBL] [Abstract][Full Text] [Related]
15. A human claudin-1-derived peptide inhibits hepatitis C virus entry.
Si Y; Liu S; Liu X; Jacobs JL; Cheng M; Niu Y; Jin Q; Wang T; Yang W
Hepatology; 2012 Aug; 56(2):507-15. PubMed ID: 22378192
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition.
Li Q; Sodroski C; Lowey B; Schweitzer CJ; Cha H; Zhang F; Liang TJ
Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7620-5. PubMed ID: 27298373
[TBL] [Abstract][Full Text] [Related]
17. Pre-stimulation of CD81 expression by resting B cells increases proliferation following EBV infection, but the overexpression of CD81 induces the apoptosis of EBV-transformed B cells.
Park GB; Kim D; Park SJ; Lee HK; Kim JH; Kim YS; Park SG; Choi IH; Yoon SH; Lee YJ; Paeng S; Hur DY
Int J Mol Med; 2015 Dec; 36(6):1464-78. PubMed ID: 26498453
[TBL] [Abstract][Full Text] [Related]
18. Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.
Qi H; Chu V; Wu NC; Chen Z; Truong S; Brar G; Su SY; Du Y; Arumugaswami V; Olson CA; Chen SH; Lin CY; Wu TT; Sun R
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2018-2023. PubMed ID: 28159892
[TBL] [Abstract][Full Text] [Related]
19. Isolate-dependent use of claudins for cell entry by hepatitis C virus.
Haid S; Grethe C; Dill MT; Heim M; Kaderali L; Pietschmann T
Hepatology; 2014 Jan; 59(1):24-34. PubMed ID: 23775920
[TBL] [Abstract][Full Text] [Related]
20. A view of the E2-CD81 interface at the binding site of a neutralizing antibody against hepatitis C virus.
Harman C; Zhong L; Ma L; Liu P; Deng L; Zhao Z; Yan H; Struble E; Virata-Theimer ML; Zhang P
J Virol; 2015 Jan; 89(1):492-501. PubMed ID: 25339761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]